The Medicare GLP-1 Bridge gives eligible beneficiaries $50/month access to Wegovy, Zepbound, or Foundayo starting July 1, 2026 — but it's explicitly temporary, ending December 31, 2027. Here's what's supposed to happen next, the real risk of a coverage gap, and what to know now.
The part most coverage leaves out: The Medicare GLP-1 Bridge is explicitly a temporary demonstration program, not permanent coverage. It is scheduled to end December 31, 2027. What replaces it — called the BALANCE Model — is not guaranteed, has already been delayed once, and depends on enough Part D insurance plans voluntarily choosing to participate.
The two-program structure CMS actually built
CMS designed two separate, sequential mechanisms to expand Medicare GLP-1 access:
- The Medicare GLP-1 Bridge — the $50/month program running July 1, 2026 through December 31, 2027. Mandatory nationwide, no plan opt-in required. Full eligibility details here.
- The BALANCE Model — intended as the longer-term successor, originally planned to begin in 2027. Unlike the Bridge, this model is voluntary for Part D insurance plans — they have to choose to participate.
The Bridge exists specifically to fill the gap while BALANCE gets built and adopted. The honest framing: the Bridge is the guaranteed part. BALANCE is the part that depends on insurance companies opting in.
Why this matters — the delay already happened
Dec 2026
Original planned end date for the Bridge program
As first announced
Dec 2027
Extended end date, confirmed by CMS
Current official timeline
2027 → ?
BALANCE Model Part D implementation already delayed once
CMS announcement, April 2026
CMS already extended the Bridge by a full year — from its original December 2026 end date to December 2027 — specifically because the longer-term replacement wasn't ready. In April 2026, CMS separately announced it is delaying implementation of the Medicare Part D portion of the BALANCE Model for calendar year 2027. That's two delays on the permanent solution within the program's first year of existing.
The realistic coverage gap risk
Health policy researchers at KFF have stated this plainly: there is a real, structural possibility that Medicare beneficiaries could have GLP-1 coverage for obesity in 2026 and 2027 under the Bridge, then lose access in 2028 if the BALANCE Model isn't fully implemented or doesn't reach sufficient Part D plan participation in time.
This isn't speculation about a hypothetical — it's the structural design of the two-program handoff. The Bridge has a hard end date. BALANCE has a soft, voluntary, not-yet-finalized start. The gap between those two realities is where the risk lives.
Even if BALANCE launches successfully: KFF notes that Part D plans participating in BALANCE could choose to drop out before the model's final year, which could interrupt treatment or force beneficiaries to switch plans repeatedly to maintain GLP-1 access. Voluntary participation cuts both ways — plans can also voluntarily leave.
Timeline — what's confirmed vs. what's still uncertain
July 1, 2026 — Bridge launches
Confirmed. $50/month copay begins for eligible beneficiaries nationwide.
2026-2027 — Bridge collects utilization data
Confirmed. CMS uses this period to share GLP-1 usage data with Part D plan sponsors ahead of BALANCE.
2027 — BALANCE Model Part D implementation (delayed)
Originally planned for this year; CMS announced a delay in April 2026. New timeline not yet finalized.
December 31, 2027 — Bridge program ends
Confirmed hard end date. No coverage continues automatically past this point.
2028 — Coverage status uncertain
Depends entirely on BALANCE Model rollout and how many Part D plans have opted in by this point.
What beneficiaries should actually do with this information
- Use the Bridge window now if you're eligible. The $50/month rate is confirmed through 2027. Waiting doesn't gain you anything and risks missing guaranteed coverage.
- Pay attention to Medicare's annual open enrollment in fall 2026 and 2027. As BALANCE Model details firm up, switching to a participating Part D plan may become necessary to maintain coverage past 2027 — this is exactly the kind of plan-switching KFF flagged as a real possibility.
- Build a backup plan now, not in late 2027. If you're benefiting from GLP-1 therapy through the Bridge, understand that compounded semaglutide or tirzepatide through telehealth remains a parallel option that doesn't depend on any Medicare program timeline. Knowing this option exists removes the pressure of a potential 2028 coverage cliff.
✅ The bottom line
The Medicare GLP-1 Bridge is real, generous, and worth using if you're eligible — but it's explicitly temporary, and what comes after it is genuinely uncertain. This isn't pessimism, it's just reading what CMS and KFF have already stated plainly. Use the confirmed window now. Watch for BALANCE Model updates during 2026-2027 open enrollment periods. And know that telehealth access to compounded GLP-1 medications exists as a coverage-independent fallback if the 2028 transition doesn't go smoothly.
Want a coverage-independent option as a backup?
DirectMeds offers physician-supervised compounded semaglutide and tirzepatide from $99-149/month — available regardless of any Medicare program timeline or plan participation status.
Check eligibility at DirectMeds →
Frequently asked questions
When does the Medicare GLP-1 Bridge program end?
The Medicare GLP-1 Bridge is scheduled to end December 31, 2027. It was originally planned to end December 2026 but was extended by CMS specifically because the longer-term replacement program, the BALANCE Model, was not ready. There is no automatic coverage extension built in past this date.
What is the BALANCE Model and how is it different from the Bridge?
The BALANCE Model is intended as the longer-term Medicare GLP-1 coverage mechanism meant to succeed the Bridge program. Unlike the Bridge, which is mandatory nationwide with no plan opt-in required, the BALANCE Model is voluntary for Medicare Part D insurance plans — each plan has to choose to participate. In April 2026, CMS announced a delay to the Part D implementation timeline for BALANCE, meaning the transition plan is not yet finalized.
Will I lose GLP-1 coverage when the Medicare Bridge program ends?
This is genuinely uncertain and depends on how the BALANCE Model rollout proceeds. KFF health policy researchers have explicitly noted the realistic possibility that beneficiaries could have coverage in 2026-2027 under the Bridge and then lose access in 2028 if BALANCE isn't fully implemented or enough Part D plans haven't opted in by then. Beneficiaries should watch Medicare open enrollment updates in fall 2026 and 2027 for guidance on which plans participate in BALANCE.